Skip to main content
Find People
Campus Map
PiratePort
A-Z
English
العربية
বাংলা
Català
Čeština
Deutsch
Ελληνικά
Español
فارسی
Suomi
Français
Gàidhlig
ગુજરાતી
हिंदी
Magyar
Italiano
Қазақ
Latviešu
मराठी
Nederlands
Polski
Português
Português do Brasil
Русский
Srpski (lat)
Српски
Svenska
தமிழ்
Türkçe
Yкраї́нська
Tiếng Việt
繁体中文
Log In
Log in
Have you forgotten your passphrase?
Communities & Collections
Browse The Scholarship
Statistics
About
Submit
Home
Health Sciences Campus
Brody School of Medicine
Microbiology and Immunology
Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia
Triple Akt Inhibition as a New Therapeutic Strategy in T-cell Acute Lymphoblastic Leukemia
Loading...
Files
McCubreyTripleAktInhibitionasaNewTherapeuticStrategy.pdf
(4.64 MB)
Date
2015-03-02
Authors
McCubrey, James A.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
T-acute lymphoblastic leukemia
,
Perifosine
,
small molecules inhibitors (SMI)
Citation
URI
http://hdl.handle.net/10342/9587
DOI
10.18632/oncotarget.3260
Collections
Microbiology and Immunology
Endorsement
Review
Supplemented By
Referenced By
Full item page